InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Miller Andrew Craig, Executive. Officer active across 1 company, notably Karuna Therapeutics, Inc.. Cumulatively, 20 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €460k. History available since 10 May 2021. The latest transaction was filed on 18 March 2024 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations20 total
13,977 shares@ US$330.0073.7% of flowCommon StockSEC:0001140361-24-013930:0
1,011 shares@ US$317.145.2% of flowCommon StockSEC:0000950170-24-013962:0
30,000 shares@ US$9.204.4% of flowCommon StockSEC:0000950170-23-013722:0
12,550 shares0Common StockSEC:0001593968-23-000302:0
7,100 shares@ US$2.920.3% of flowCommon StockSEC:0001593968-22-001764:0
250 shares@ US$7.270.0% of flowCommon StockSEC:0001593968-22-001691:0
1,000 shares@ US$7.270.1% of flowCommon StockSEC:0001593968-22-001596:0
2,000 shares@ US$2.920.1% of flowCommon StockSEC:0001593968-22-001570:0
26,500 shares@ US$2.921.2% of flowCommon StockSEC:0001593968-21-002357
26,500 shares@ US$2.927.2% of flowCommon StockSEC:0001593968-21-002357:0
700 shares@ US$118.557.7% of flowCommon StockSEC:0001593968-21-002238:0
700 shares@ US$118.551.2% of flowCommon StockSEC:0001593968-21-002238
1,590 shares@ US$117.872.8% of flowCommon StockSEC:0001593968-21-002085
1,590 shares@ US$117.8717.0% of flowCommon StockSEC:0001593968-21-002085:0
12,500 shares@ US$2.923.3% of flowCommon StockSEC:0001593968-21-001993:0
12,500 shares@ US$2.920.5% of flowCommon StockSEC:0001593968-21-001993
13,333 shares@ US$9.201.8% of flowCommon StockSEC:0001593968-21-001617
13,333 shares@ US$9.2010.8% of flowCommon StockSEC:0001593968-21-001617:0
5,000 shares@ US$9.204.1% of flowCommon StockSEC:0001593968-21-001293:0
5,000 shares@ US$9.204.1% of flowCommon StockSEC:0001593968-21-001293
20 of 20 declarations
About Miller Andrew Craig
Andrew Craig Miller is the Chief Operating Officer at Karuna Therapeutics, Inc. He is responsible for managing the company's operations and strategy. Andrew Craig Miller plays a key role in improving operational processes and product development. His expertise in business management and operations is essential to ensure that Karuna Therapeutics, Inc. meets its growth and innovation objectives.
